Status:
UNKNOWN
Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in Schizophrenia
Lead Sponsor:
Seoul National Hospital
Conditions:
Schizophrenia
Metabolic Syndrome
Eligibility:
All Genders
18-65 years
Brief Summary
We are going to investigate the association of multiple genetic polymorphisms with the metabolic side effects in patients with schizophrenia taking clozapine.
Detailed Description
The use of antipsychotics, especially clozapine and olanzapine is associated with metabolic side effects, which put patients with schizophrenia at risk for cardiovascular morbidity or diabetes. The p...
Eligibility Criteria
Inclusion
- age 18-65
- who can understand and sign the informed consent
Exclusion
- who refuse to participate this study
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2009
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00717509
Start Date
October 1 2007
End Date
October 1 2009
Last Update
June 12 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National Hospital
Seoul, South Korea, 139-757